FDA Warns of Side Effects of Popular Hair-Loss Drug Sold by Telehealth Companies - WSJ
5 days ago • Google News
Hims Hers Health Inc (HIMS)
US$ 28.09-0.18%
Price Chart
Key Statistics
Market Cap
$ 6.25B
P/E Ratio
53.00
Revenue (TTM)
$ 1.48B
Volume
13.23M
52W High
$ 72.98
52W Low
$ 11.20
Dividend Yield
0.00%
Beta
1.66
Technicals
50-Day MA
36.1618
200-Day MA
26.6742
52 Week High
72.98
52 Week Low
11.2
About HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally.
Employees
1637
Headquarters
San Francisco, CA
CEO
Mr. Andrew Dudum
Latest News
Hims & Hers: Top Pick For The Next Decade (NYSE:HIMS) - Seeking Alpha
6 days ago • Google News
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025 - Business Wire
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg